286 related articles for article (PubMed ID: 18821585)
1. Leptin signaling in breast cancer: an overview.
Cirillo D; Rachiglio AM; la Montagna R; Giordano A; Normanno N
J Cell Biochem; 2008 Nov; 105(4):956-64. PubMed ID: 18821585
[TBL] [Abstract][Full Text] [Related]
2. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
[TBL] [Abstract][Full Text] [Related]
3. Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (review).
Rose DP; Gilhooly EM; Nixon DW
Int J Oncol; 2002 Dec; 21(6):1285-92. PubMed ID: 12429979
[TBL] [Abstract][Full Text] [Related]
4. Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3 pathway in colorectal cancer cells.
Cascio S; Ferla R; D'Andrea A; Gerbino A; Bazan V; Surmacz E; Russo A
J Cell Physiol; 2009 Oct; 221(1):189-94. PubMed ID: 19492417
[TBL] [Abstract][Full Text] [Related]
5. Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression.
Perera CN; Chin HG; Duru N; Camarillo IG
J Endocrinol; 2008 Nov; 199(2):221-33. PubMed ID: 18715880
[TBL] [Abstract][Full Text] [Related]
6. Leptin augments proliferation of breast cancer cells via transactivation of HER2.
Soma D; Kitayama J; Yamashita H; Miyato H; Ishikawa M; Nagawa H
J Surg Res; 2008 Sep; 149(1):9-14. PubMed ID: 18262553
[TBL] [Abstract][Full Text] [Related]
7. Procollagen I COOH-terminal fragment induces VEGF-A and CXCR4 expression in breast carcinoma cells.
Palmieri D; Astigiano S; Barbieri O; Ferrari N; Marchisio S; Ulivi V; Volta C; Manduca P
Exp Cell Res; 2008 Jul; 314(11-12):2289-98. PubMed ID: 18570923
[TBL] [Abstract][Full Text] [Related]
8. Obesity hormone leptin: a new target in breast cancer?
Surmacz E
Breast Cancer Res; 2007; 9(1):301. PubMed ID: 17274833
[TBL] [Abstract][Full Text] [Related]
9. The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancer.
Boulay A; Breuleux M; Stephan C; Fux C; Brisken C; Fiche M; Wartmann M; Stumm M; Lane HA; Hynes NE
Cancer Res; 2008 May; 68(10):3743-51. PubMed ID: 18483257
[TBL] [Abstract][Full Text] [Related]
10. Obesity and breast cancer: status of leptin and adiponectin in pathological processes.
Grossmann ME; Ray A; Nkhata KJ; Malakhov DA; Rogozina OP; Dogan S; Cleary MP
Cancer Metastasis Rev; 2010 Dec; 29(4):641-53. PubMed ID: 20821253
[TBL] [Abstract][Full Text] [Related]
11. Leptin activates STAT and ERK2 pathways and induces gastric cancer cell proliferation.
Pai R; Lin C; Tran T; Tarnawski A
Biochem Biophys Res Commun; 2005 Jun; 331(4):984-92. PubMed ID: 15882975
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer.
Otvos L; Kovalszky I; Riolfi M; Ferla R; Olah J; Sztodola A; Nama K; Molino A; Piubello Q; Wade JD; Surmacz E
Eur J Cancer; 2011 Jul; 47(10):1578-84. PubMed ID: 21353530
[TBL] [Abstract][Full Text] [Related]
13. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression.
Vona-Davis L; Rose DP
Endocr Relat Cancer; 2007 Jun; 14(2):189-206. PubMed ID: 17639037
[TBL] [Abstract][Full Text] [Related]
14. Leptin and leptin receptor involvement in cancer development: a study on human primary breast carcinoma.
Jardé T; Caldefie-Chézet F; Damez M; Mishellany F; Penault-Llorca F; Guillot J; Vasson MP
Oncol Rep; 2008 Apr; 19(4):905-11. PubMed ID: 18357374
[TBL] [Abstract][Full Text] [Related]
15. Role of the long form leptin receptor and of the STAT3 signaling pathway in colorectal cancer progression.
Uchiyama T; Takahashi H; Endo H; Sugiyama M; Sakai E; Hosono K; Nagashima Y; Inayama Y; Wada K; Hippo Y; Nakajima A
Int J Oncol; 2011 Oct; 39(4):935-40. PubMed ID: 21720710
[TBL] [Abstract][Full Text] [Related]
16. TOB1 is regulated by EGF-dependent HER2 and EGFR signaling, is highly phosphorylated, and indicates poor prognosis in node-negative breast cancer.
Helms MW; Kemming D; Contag CH; Pospisil H; Bartkowiak K; Wang A; Chang SY; Buerger H; Brandt BH
Cancer Res; 2009 Jun; 69(12):5049-56. PubMed ID: 19491269
[TBL] [Abstract][Full Text] [Related]
17. Mammary tumor development from T47-D human breast cancer cells in obese ovariectomized mice with and without estradiol supplements.
Nkhata KJ; Ray A; Dogan S; Grande JP; Cleary MP
Breast Cancer Res Treat; 2009 Mar; 114(1):71-83. PubMed ID: 18392696
[TBL] [Abstract][Full Text] [Related]
18. Adipocyte expression and circulating levels of leptin increase in both gynaecological and breast cancer patients.
Tessitore L; Vizio B; Pesola D; Cecchini F; Mussa A; Argiles JM; Benedetto C
Int J Oncol; 2004 Jun; 24(6):1529-35. PubMed ID: 15138597
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells.
Watt HL; Kharmate GD; Kumar U
Cell Signal; 2009 Mar; 21(3):428-39. PubMed ID: 19070659
[TBL] [Abstract][Full Text] [Related]
20. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.
Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B
Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
